CMGSX
Price
$34.93
Change
+$0.15 (+0.43%)
Updated
Jun 22 closing price
Net Assets
5.61B
VMGMX
Price
$132.08
Change
+$0.31 (+0.24%)
Updated
Jun 22 closing price
Net Assets
33.76B
Interact to see
Advertisement

CMGSX vs VMGMX

CMGSX vs VMGMX Comparison Chart in %
View a ticker or compare two or three
VS
CMGSX vs. VMGMX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMGSX is a Hold and VMGMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMGMX has more cash in the bank: 33.8B vs. CMGSX (5.61B). VMGMX pays higher dividends than CMGSX: VMGMX (0.62) vs CMGSX (0.00). CMGSX was incepted earlier than VMGMX: CMGSX (30 years) vs VMGMX (15 years). CMGSX (1.14) is less costly to investors than VMGMX (0.07). CMGSX is a more actively managed with annual turnover of: 87.00 vs. VMGMX (17.00). VMGMX has a lower initial minimum investment than CMGSX: VMGMX (3000) vs CMGSX (5000). VMGMX annual gain was more profitable for investors over the last year : 11.76 vs. CMGSX (-10.25). VMGMX return over 5 years is better than : 31.10 vs. CMGSX (-19.00).
CMGSXVMGMXCMGSX / VMGMX
Total Expense Ratio1.050.071,500%
Annual Report Gross Expense Ratio1.140.071,629%
Fund Existence30 years15 years-
Gain YTD11.5469.952116%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets5.61B33.8B17%
Annual Yield % from dividends0.000.62-
Returns for 1 year-10.2511.76-87%
Returns for 3 years14.6055.5326%
Returns for 5 years-19.0031.10-61%
Returns for 10 years135.64213.1364%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX22.59N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
MRICX26.84N/A
N/A
MFS Research International C
ICSSX16.85N/A
N/A
VY® Columbia Small Cp Val & InflectionS
ALVDX11.09N/A
N/A
American Century Focused Lg Cap Val R6
BRUMX18.35N/A
N/A
MFS Blended Research Value Equity R4